• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超冷向列相纳米粒子:基质组成和体外细胞毒性的影响。

Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.

机构信息

Lehrstuhl für Pharmazeutische Technologie, Friedrich-Schiller-Universität Jena, Lessingstr. 8, D-07743 Jena, Germany.

出版信息

Eur J Pharm Sci. 2009 Oct 8;38(3):238-48. doi: 10.1016/j.ejps.2009.07.012. Epub 2009 Aug 5.

DOI:10.1016/j.ejps.2009.07.012
PMID:19664705
Abstract

Cholesteryl nonanoate (CN), myristate (CM), palmitate (CP) and oleate (CO) alone or in combination were evaluated as matrix lipids for the preparation of supercooled smectic nanoparticles with a high stability against recrystallization during storage. The phase behavior of the cholesterol esters in the bulk was studied by polarizing light microscopy, differential scanning calorimetry (DSC) and small angle X-ray scattering (SAXS). Colloidal dispersions with pure and mixed cholesterol ester matrices were prepared by high-pressure melt homogenization and characterized by photon correlation spectroscopy, laser diffraction combined with polarizing intensity differential scattering, DSC and SAXS. The morphology of selected formulations was studied by freeze-fracture electron microscopy. All smectic nanoparticles with a mixed cholesterol ester matrix were stable against recrystallization when stored at room temperature. Nanoparticles with a pure CN and mixed CM/CN matrix with a high fraction of CN (60% of the whole lipid matrix) could even be stored at 4 degrees C for at least 18 months without any recrystallization. As smectic nanoparticles are studied especially with regard to parenteral administration of lipophilic drugs, the cytotoxicity of selected formulations was compared with that of a clinically used colloidal fat emulsion (Lipofundin MCT) in the murine fibroblast cell line L929 using the sulforhodamine B assay. The supercooled smectic nanoparticle formulations display a good overall cell compatibility although in some cases their cytotoxicity was slightly higher than that of Lipofundin MCT.

摘要

胆固醇壬酸酯(CN)、肉豆蔻酸酯(CM)、棕榈酸酯(CP)和油酸酯(CO)单独或组合用作基质脂质,用于制备超冷层状纳米粒子,在储存过程中具有高稳定性,防止重结晶。通过偏光显微镜、差示扫描量热法(DSC)和小角 X 射线散射(SAXS)研究胆固醇酯在本体中的相行为。通过高压熔融匀化制备具有纯和混合胆固醇酯基质的胶体分散体,并通过光子相关光谱法、激光衍射与偏振强度差散射相结合、DSC 和 SAXS 进行表征。通过冷冻断裂电子显微镜研究了选定配方的形态。当在室温下储存时,具有混合胆固醇酯基质的所有层状纳米粒子都能稳定地防止重结晶。具有纯 CN 和混合 CM/CN 基质(CN 占整个脂质基质的 60%)的纳米粒子甚至可以在 4°C 下储存至少 18 个月而不会发生任何重结晶。由于层状纳米粒子尤其被研究用于亲脂性药物的肠胃外给药,因此使用 Sulforhodamine B 测定法在小鼠成纤维细胞系 L929 中比较了选定配方的细胞毒性与临床使用的胶体脂肪乳剂(Lipofundin MCT)的细胞毒性。尽管在某些情况下,超冷层状纳米粒子制剂的细胞毒性略高于 Lipofundin MCT,但它们具有良好的整体细胞相容性。

相似文献

1
Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.超冷向列相纳米粒子:基质组成和体外细胞毒性的影响。
Eur J Pharm Sci. 2009 Oct 8;38(3):238-48. doi: 10.1016/j.ejps.2009.07.012. Epub 2009 Aug 5.
2
Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.稳定剂体系对过冷向列纳米粒子性质和相行为的影响。
J Colloid Interface Sci. 2010 Oct 1;350(1):229-39. doi: 10.1016/j.jcis.2010.06.018. Epub 2010 Jun 15.
3
Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers.含有磷脂作为稳定剂的过冷近晶型肉豆蔻酸胆固醇酯纳米颗粒的结晶行为。
Colloids Surf B Biointerfaces. 2005 Jul 25;44(1):25-35. doi: 10.1016/j.colsurfb.2005.05.007.
4
Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles.制备条件和热处理对过冷近晶型肉豆蔻酸胆固醇酯纳米颗粒性能的影响。
Eur J Pharm Biopharm. 2007 Nov;67(3):612-20. doi: 10.1016/j.ejpb.2007.04.019. Epub 2007 May 5.
5
PEGylation of supercooled smectic cholesteryl myristate nanoparticles.超冷各向同性胆甾醇肉豆蔻酸纳米粒子的聚乙二醇化。
Eur J Pharm Biopharm. 2012 Jun;81(2):409-17. doi: 10.1016/j.ejpb.2012.03.011. Epub 2012 Apr 2.
6
Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.过冷近晶相纳米颗粒:一种用于难溶性药物的潜在新型载体系统。
Pharm Res. 2004 Oct;21(10):1834-43. doi: 10.1023/b:pham.0000045237.46019.6e.
7
Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.聚乙烯醇作为乳化剂可稳定α-晶型的固体甘油三酯药物载体纳米颗粒。
Mol Pharm. 2009 Jan-Feb;6(1):105-20. doi: 10.1021/mp8000759.
8
Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.含有混合脂质核心和极性异质脂质的固体脂质纳米分散体:表征
Eur J Pharm Biopharm. 2007 Aug;67(1):48-57. doi: 10.1016/j.ejpb.2006.12.004. Epub 2006 Dec 16.
9
Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.用杂脂质模板化同脂质制备的表面改性固体脂质纳米容器的研究。
Int J Pharm. 2007 Apr 4;334(1-2):179-89. doi: 10.1016/j.ijpharm.2006.10.032. Epub 2006 Oct 28.
10
Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).表面活性剂表面覆盖率对固体脂质纳米粒(SLN)形成的影响。
J Colloid Interface Sci. 2009 Jun 1;334(1):75-81. doi: 10.1016/j.jcis.2009.03.012. Epub 2009 Mar 28.

引用本文的文献

1
Transfer Investigations of Lipophilic Drugs from Lipid Nanoemulsions to Lipophilic Acceptors: Contributing Effects of Cholesteryl Esters and Albumin as Acceptor Structures.亲脂性药物从脂质纳米乳剂向亲脂性受体的转移研究:胆固醇酯和白蛋白作为受体结构的贡献作用。
Pharmaceuticals (Basel). 2021 Aug 28;14(9):865. doi: 10.3390/ph14090865.
2
Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10.用于提高辅酶Q10口服生物利用度的新型无脂质纳米制剂。
Biomed Res Int. 2014;2014:793879. doi: 10.1155/2014/793879. Epub 2014 Jun 5.
3
Characterisation and Skin Distribution of Lecithin-Based Coenzyme Q10-Loaded Lipid Nanocapsules.
基于卵磷脂的辅酶Q10负载脂质纳米胶囊的表征及其皮肤分布
Nanoscale Res Lett. 2010 Jul 20;5(10):1561-9. doi: 10.1007/s11671-010-9677-z.